Schedule a consultation with a clinician trained in peptide therapy to determine whether the GLOW protocol aligns with your injury, goals, and recovery timeline.
They can evaluate you, look at a blood sample, and determine whether you have a deficiency
Love this shot
The introduction of wortmannin was found to significantly reverse the expression of PI3K and AKT, as well as the anti-apoptotic and anti-inflammatory effects of Dihexa, resulting in a decrease in the number of neuronal cells present in the cortex and the levels of IL-10, and an increase in the levels of TNF-alpha and IL-1-beta [1]
Over time, inflammation can shift how the gut moves
Injection Techniques BPC-157 and TB500 are typically administered subcutaneously (subQ) near the injury site for local effect, or systemically (lower abdomen) for general recovery